Published in J Immunol Res on April 20, 2015
Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses. Front Microbiol (2017) 0.75
An Overview of B-1 Cells as Antigen-Presenting Cells. Front Immunol (2016) 0.75
Multiple Activities of Punica granatum Linne against Acne Vulgaris. Int J Mol Sci (2017) 0.75
The Three-Herb Formula Shuang-Huang-Lian stabilizes mast cells through activation of mitochondrial calcium uniporter. Sci Rep (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature (1995) 10.89
CD28/B7 system of T cell costimulation. Annu Rev Immunol (1996) 10.48
A SIMPLE METHOD FOR PREPARING ANTIGENIC SUBSTANCES FROM THE TYPHOID BACILLUS. Science (1940) 10.11
Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med (2002) 9.14
A colorimetric method for the determination of sugars. Nature (1951) 8.76
Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med (1988) 4.60
[STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM]. J Reticuloendothel Soc (1964) 3.93
Inhibition of tumour growth by administration of killed corynebacterium parvum. Nature (1966) 3.81
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
CD8- dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol (2001) 2.42
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol (2002) 2.14
Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum. Exp Parasitol (1967) 2.06
Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol (2010) 2.02
TLR9 signaling in B cells determines class switch recombination to IgG2a. J Immunol (2007) 1.95
Th17 cells: new players in asthma pathogenesis. Allergy (2011) 1.64
Cutting edge: Th2 response induction by dendritic cells: a role for CD40. J Immunol (2002) 1.60
Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J Immunol (1997) 1.58
Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol (2005) 1.54
Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol (1996) 1.49
Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol (2003) 1.46
Age-related changes in the resident bacterial flora of the human face. J Invest Dermatol (1975) 1.41
Expression of toll-like receptors on B lymphocytes. Cell Immunol (2005) 1.33
Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet (2002) 1.33
Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol (2005) 1.26
Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.24
Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury. J Hepatol (2006) 1.22
Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. J Allergy Clin Immunol (2004) 1.12
Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production. J Immunol (1999) 1.10
Propionibacterium acnes colonization in acne and nonacne. Dermatology (1998) 1.10
Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. J Immunol (2000) 1.10
Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice. Hepatology (2004) 1.06
B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease. PLoS One (2008) 1.01
Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes. Immunology (1975) 1.00
Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol (2006) 0.95
Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene. Microbiol Immunol (2006) 0.91
Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity. Scand J Immunol (2007) 0.90
Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. J Leukoc Biol (1993) 0.88
Immunobiology of toll-like receptors in allergic disease. Immunobiology (2007) 0.85
Adjuvant effect of killed Propionibacterium acnes on mouse peritoneal B-1 lymphocytes and their early phagocyte differentiation. PLoS One (2012) 0.83
In vivo and in vitro effect of killed Propionibacterium acnes and its purified soluble polysaccharide on mouse bone marrow stem cells and dendritic cell differentiation. Immunobiology (2005) 0.83
Treatment with Propionibacterium acnes modulates the late phase reaction of immediate hypersensitivity in mice. Immunol Lett (2003) 0.82
Nonspecific resistance against Trypanosoma cruzi enhanced by Corynebacterium parvum. J Parasitol (1976) 0.82
Modulation of the type I hypersensitivity late phase reaction to OVA by Propionibacterium acnes-soluble polysaccharide. Immunol Lett (2008) 0.81
The polysaccharide fraction of Propionibacterium acnes modulates the development of experimental focal segmental glomerulosclerosis. Immunobiology (2011) 0.81
A novel murine model of late-phase reaction of immediate hypersensitivity. Mediators Inflamm (1997) 0.80
Propionibacterium acnes activates caspase-1 in human neutrophils. APMIS (2012) 0.77